Effect of prolonged hemodialysis on SOD activity and relative telomere length in chronic kidney disease patients – potential improving of cardiovascular disease outcomes

2021 ◽  
Vol 177 ◽  
pp. S78
Author(s):  
Azra Guzonjić ◽  
Marija Dobričić ◽  
Višnja Ležaić ◽  
Milica Miljković ◽  
Tamara Antonić ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Telomere Length ◽  
Sod Activity ◽  
Disease Outcomes ◽  
Relative Telomere Length

Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: The GCKD study

2015 ◽  
Vol 242 (2) ◽  
pp. 529-534 ◽  
Author(s):  
Julia Raschenberger ◽  
Barbara Kollerits ◽  
Stephanie Titze ◽  
Anna Köttgen ◽  
Barbara Bärthlein ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Telomere Length ◽  
Relative Telomere Length

scholarly journals Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation

2018 ◽  
Vol 15 (12) ◽  
pp. 2733 ◽  
Author(s):  
Chamberlain Obialo ◽  
Elizabeth Ofili ◽  
Keith Norris
Keyword(s):  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
General Population ◽  
Risk Reduction ◽  
Survival Advantage ◽  
End Stage Kidney Disease ◽  
Cvd Risk ◽  
Disease Outcomes ◽  
End Stage

Cardiovascular disease (CVD) burden is several-fold higher in patients with chronic kidney disease (CKD). Although statins have been shown to provide significant CVD benefits in both the general population and patients with CKD, this has not translated into survival advantage in patients with advanced CKD or on dialysis. It has been reported that CVD risk continues to escalate as CKD progresses to end-stage kidney disease (ESKD); however, the CVD risk reduction by statins appears to decline as patients’ progress from the early to later stages of CKD. Statins have also been associated with a higher incidence of stroke in ESKD patients. Thus, the CVD benefits of statins in ESKD remain questionable.

scholarly journals Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Julia Raschenberger ◽  
Barbara Kollerits ◽  
James Ritchie ◽  
Beverley Lane ◽  
Philip A. Kalra ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Telomere Length ◽  
Effect Modification ◽  
Relative Telomere Length

Stentul JJ ureteral - care este optiunea mai buna? New Considerations Regarding Chronic Kidney Disease, Cardiovascular Disease and Dyslipidemia in Diabetic Patients

2018 ◽  
Vol 69 (8) ◽  
pp. 2064-2066
Author(s):  
Mircea Munteanu ◽  
Adrian Apostol ◽  
Viviana Ivan
Keyword(s):  
Cardiovascular Disease ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Total Cholesterol ◽  
Total Cholesterol Level ◽  
Vascular Complications ◽  
Hdl Cholesterol ◽  
Controlled Study ◽  
Diabetic Patients ◽  
Artery Disease

The aim of the present study is to investigate the prevalance of chronic kidney disease (CKD), of cardiovascular disease (CVD) and dyslipidemia in patients with diabetes mellitus (DM). We conducted a prospective, controlled study involving 420 diabetic patients (120 T1DM, 300 T2DM) and investigate the following aspects: the presence of vascular complications (stroke, coronary artery disease, peripheral artery disease), lipid profile (total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides), kidney function (glomerular filtration rate, albuminuria), blood pressure, HbA1C. The results that in diabetic patients with CKD there is an increased prevalence of CVD and of dislipidemia. Also we noticed a negative correlation between total cholesterol level and decease in eGFR in all patients, with or without CKD.

Sign in / Sign up

Export Citation Format

Share Document